IP Verse

Novel Lipid Formulations For Nucleic Acid Delivery - EP2279254

The patent EP2279254 was granted to Arbutus Biopharma on Jul 5, 2017. The application was originally filed on Apr 15, 2009 under application number EP09731866A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2279254

ARBUTUS BIOPHARMA
Application Number
EP09731866A
Filing Date
Apr 15, 2009
Status
Granted And Under Opposition
Jun 2, 2017
Grant Date
Jul 5, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MERCK SHARP & DOHMEApr 5, 2018CARPMAELS & RANSFORDADMISSIBLE
MERCK SHARP & DOHMEApr 5, 2018VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE
MODERNAApr 5, 2018HOFFMANN EITLEADMISSIBLE

Patent Citations (162) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP19920110298-
DESCRIPTIONUS20070807872-
DESCRIPTIONUS20080104212-
DESCRIPTIONUS20080343342-
DESCRIPTIONUS20090147235-
DESCRIPTIONUS20090162127-
DESCRIPTIONWO2008US88676-
DESCRIPTIONCA2456444
DESCRIPTIONEP0360257
DESCRIPTIONGB2396864
DESCRIPTIONGB2397818
DESCRIPTIONUS2002072121
DESCRIPTIONUS2002081736
DESCRIPTIONUS2003026831
DESCRIPTIONUS2003073640
DESCRIPTIONUS2003077829
DESCRIPTIONUS2003082103
DESCRIPTIONUS2003130186
DESCRIPTIONUS2004110296
DESCRIPTIONUS2004142025
DESCRIPTIONUS2004142895
DESCRIPTIONUS2004167090
DESCRIPTIONUS2004192626
DESCRIPTIONUS2004249178
DESCRIPTIONUS2005008689
DESCRIPTIONUS2005043219
DESCRIPTIONUS2005058982
DESCRIPTIONUS2005064595
DESCRIPTIONUS2005074771
DESCRIPTIONUS2005107316
DESCRIPTIONUS2005107325
DESCRIPTIONUS2005119470
DESCRIPTIONUS2005153337
DESCRIPTIONUS2005158727
DESCRIPTIONUS2005239739
DESCRIPTIONUS2005282188
DESCRIPTIONUS2006008910
DESCRIPTIONUS2006083780
DESCRIPTIONUS2006134189
DESCRIPTIONUS2006240554
DESCRIPTIONUS2006281175
DESCRIPTIONUS2007042031
DESCRIPTIONUS2007135370
DESCRIPTIONUS2007135372
DESCRIPTIONUS2007149470
DESCRIPTIONUS2007218122
DESCRIPTIONUS2007265438
DESCRIPTIONUS3817827
DESCRIPTIONUS3850752
DESCRIPTIONUS3901654
DESCRIPTIONUS3935074
DESCRIPTIONUS3984533
DESCRIPTIONUS3993754
DESCRIPTIONUS3996345
DESCRIPTIONUS4034074
DESCRIPTIONUS4098876
DESCRIPTIONUS4145410
DESCRIPTIONUS4224179
DESCRIPTIONUS4235871
DESCRIPTIONUS4376110
DESCRIPTIONUS4452901
DESCRIPTIONUS4522803
DESCRIPTIONUS4588578
DESCRIPTIONUS4683195
DESCRIPTIONUS4683202
DESCRIPTIONUS4737323
DESCRIPTIONUS4987071
DESCRIPTIONUS5208036
DESCRIPTIONUS5264618
DESCRIPTIONUS5279833
DESCRIPTIONUS5283185
DESCRIPTIONUS5286634
DESCRIPTIONUS5334711
DESCRIPTIONUS5426039
DESCRIPTIONUS5580579
DESCRIPTIONUS5591317
DESCRIPTIONUS5610288
DESCRIPTIONUS5631359
DESCRIPTIONUS5639725
DESCRIPTIONUS5641515
DESCRIPTIONUS5705385
DESCRIPTIONUS5718709
DESCRIPTIONUS5725871
DESCRIPTIONUS5739119
DESCRIPTIONUS5747470
DESCRIPTIONUS5753613
DESCRIPTIONUS5756353
DESCRIPTIONUS5759829
DESCRIPTIONUS5780045
DESCRIPTIONUS5783683
DESCRIPTIONUS5785992
DESCRIPTIONUS5789573
DESCRIPTIONUS5792451
DESCRIPTIONUS5801154
DESCRIPTIONUS5804212
DESCRIPTIONUS5885613
DESCRIPTIONUS5976567
DESCRIPTIONUS5981501
DESCRIPTIONUS5998203
DESCRIPTIONUS6110745
DESCRIPTIONUS6174861
DESCRIPTIONUS6320017
DESCRIPTIONUS6406705
DESCRIPTIONUS6429200
DESCRIPTIONUS6458382
DESCRIPTIONUS6534484
DESCRIPTIONUS6586410
DESCRIPTIONUS6586559
DESCRIPTIONUS6713069
DESCRIPTIONUS6753423
DESCRIPTIONUS6774180
DESCRIPTIONUS6852334
DESCRIPTIONUS7053150
DESCRIPTIONUS7348314
DESCRIPTIONUS7404969
DESCRIPTIONWO0003683
DESCRIPTIONWO0062813
DESCRIPTIONWO0115726
DESCRIPTIONWO02069369
DESCRIPTIONWO2004002453
DESCRIPTIONWO2005007196
DESCRIPTIONWO2005026372
DESCRIPTIONWO2005035764
DESCRIPTIONWO2005120152
DESCRIPTIONWO2005121348
DESCRIPTIONWO2006002538
DESCRIPTIONWO2006053430
DESCRIPTIONWO2007056861
DESCRIPTIONWO9103162
DESCRIPTIONWO9207065
DESCRIPTIONWO9315187
DESCRIPTIONWO9323569
DESCRIPTIONWO9402595
DESCRIPTIONWO9413688
DESCRIPTIONWO9610390
DESCRIPTIONWO9611266
DESCRIPTIONWO9640964
INTERNATIONAL-SEARCH-REPORTUS2005064595
INTERNATIONAL-SEARCH-REPORTUS2006008910
INTERNATIONAL-SEARCH-REPORTUS2007042031
OPPOSITIONEP1648519
OPPOSITIONEP2567693
OPPOSITIONUS2005064595
OPPOSITIONUS2006008910
OPPOSITIONUS2006240554
OPPOSITIONUS2007042031
OPPOSITIONUS2008020058
OPPOSITIONUS2008317839
OPPOSITIONUS5264618
OPPOSITIONUS9364435
OPPOSITIONWO2005007196
OPPOSITIONWO2005035764
OPPOSITIONWO2005120152
OPPOSITIONWO2006002538
OPPOSITIONWO2006053430
OPPOSITIONWO2007056861
OPPOSITIONWO2009127060
SEARCHWO2005035764
SEARCHWO2005120152
SEARCHWO2006002538
SEARCHWO2006053430
SEARCHWO2007056861

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- AHMAD A et al., "New multivalent cationic lipids reveal bell curve fortransfection efficiency versus membrane chargedensity: lipid-DNA complexes for gene delivery", J Gene Med, (20050131), vol. 7, no. 6, pages 739 - 748, XP055479069-
OPPOSITION- AHMAD et al., "New multivalent cationic lipids reveal bell curve for transfection efficiency versus membrane charge density: lipid-DNA complexes for gene delivery", J Gene Med, (20050000), vol. 7, pages 739 - 748, XP055479069-
OPPOSITION- "Chapter 9: Liposomal Formulations for Nucleic Acid Delivery", MACLACHLAN, Antisense Drug Technology, (20070000), pages 237 - 270, XP002584305-
OPPOSITION- BENNETT et al., "Cholesterol Enhances Cationic Liposome-Mediated DNA Transfection of Human Respiratory Epithelial Cells", Bioscience Reports, (19950000), vol. 15, pages 47 - 53, XP000196643
OPPOSITION- LI et al., "Lipid-based Nanoparticles for Nucleic Acid Delivery", Pharmaceutical Research, (20070000), vol. 24, no. 3, pages 438 - 449, XP019483494
OPPOSITION- HEYES et al., "Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids", Journal of Controlled Release, (20050000), vol. 107, pages 276 - 278, XP005076220
OPPOSITION- LIN AJ et al., "Three-Dimensional Imaging of Lipid Gene-Carriers: Membrane Charge Density Controls Universal Transfection Behavior in Lamellar Cationic Liposome-DNA Complexes", Biophys J, (20030000), vol. 84, no. 5, pages 3307 - 3316, XP029291912
OPPOSITION- LIN et al., "Three-Dimensional Imaging of Lipid Gene -Carriers: Membrane Charge Density Controls Universal Transfection Behavior in Lamellar Cationic Liposome-DNA Complexes", Biophysical Journal, (20030000), vol. 84, pages 3307 - 3316, XP029291912
OPPOSITION- GAO et al., "Nonviral Gene Delivery: What We Know and What Is Next", AAPS Journal, (20070000), vol. 9, no. 1, XP035718883
OPPOSITION- GAO X et al., "Nonviral Gene Delivery: What We Know and What Is Next", AAPS J, (20070323), vol. 9, no. 1, pages 92 - 104, XP035718883

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents